StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

CytoMed Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -0.34 SGD. The highest annual figure on record is -0.22 SGD in fiscal 2024.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-0.34 SGD–
FY2024Dec 31, 2024-0.22 SGD–
FY2023Dec 31, 2023-0.39 SGD–
FY2022Dec 31, 2022-0.40 SGD–
FY2021Dec 31, 2021-0.30 SGD–
FY2020Dec 31, 2020-0.33 SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?